Table 1.
Characteristics of the Study Participants
| All (N=80) | Group A (N=40) | Group B (N=40) | |
|---|---|---|---|
| Age at Randomization (yrs) | |||
| Mean (SD) | 42.3 (11.9) | 42.7 (13.5) | 41.9 (10.1) |
| Range | 18 – 69 | 18 – 69 | 20 – 62 |
| Diabetes Duration at Randomization (yrs) | |||
| Mean (SD) | 21 (12) | 20 (12) | 22 (12) |
| Range | 1 – 50 | 1 – 50 | 1 – 46 |
| Prior Continuous Glucose Monitor Use | |||
| Never | 10 | 4 | 6 |
| Past | 6 | 3 | 3 |
| Current | 64 | 33 | 31 |
| BMI at Enrollmennt (kg per m2) | |||
| Mean (SD) | 29.4 (5.7) | 29.2 (5.3) | 29.6 (6.1) |
| Range | 18.8 – 53.0 | 18.8 – 42.2 | 21.2 – 53.0 |
| Sex | |||
| Female N (%) | 53 (66%) | 27 (68%) | 26 (65%) |
| HbA1c at Randomization – Lab | |||
| Mean ± SD | 7.42 ± 1.03 | 7.60 ± 1.08 | 7.24 ± 0.97 |
| Range | 5.4 – 10.6 | 5.4 – 10.6 | 5.4 – 10.0 |
| HbA1c after Study Session (Mean ± SD) | |||
| Session 1 (A: SAP; B: E-N CLC) | 7.15 ± 0.80 | 7.30 ± 0.83 | 7.01 ± 0.76 |
| Session 2 (A: E-N CLC; B: 24–7 CLC) | 7.04 ±.0.74 | 7.12 ± 0.79 | 6.95 ± 0.68 |
| Session 3 (A: 24–7 CLC; B: E-N CLC) | 7.10 ± 0.88 | 7.13 ± 0.80 | 7.06 ± 0.95 |
| Session 4 (A: E-N CLC; B: SAP) | 7.11 ± 0.86 | 7.10 ± 0.73 | 7.12 ± 0.97 |